Le Lézard
Classified in: Health
Subjects: TRI, IMA

Servier receives a positive CHMP opinion for Tibsovo® in IDH1-mutated Acute Myeloid Leukemia (AML) and Cholangiocarcinoma (CCA) patients


PARIS, Feb. 24, 2023 /PRNewswire/ -- Servier, a global pharmaceutical company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion and recommended granting a marketing authorization for Tibsovo® (ivosidenib tablets) - an inhibitor of the mutated isocitrate dehydrogenase-1 (IDH1) enzyme - for two indications:

Claude Bertrand, Executive Vice President R&D of Servier, said: "The positive CHMP opinion is a further step towards the availability, in the European Union, of Tibsovo® which is the first IDH1 inhibitor to be recommended for approval in Europe for patients with Acute Myeloid Leukemia and Cholangiocarcinoma for whom therapeutic options are very limited. Tibsovo® is an illustration of the Group's transformation and commitment in oncology which focuses its research on hard-to-treat cancers with the development of targeted therapies being a promising path for patients." 

The positive CHMP opinion is based on clinical data from the AGILE (AML) and ClarIDHy (CCA) studies.

The CHMP's positive opinion on Tibsovo® in IDH1 mutated AML and CCA patients will be referred to the European Commission (EC) which will deliver a final decision in the coming months. The decision will be applicable to all 27 EU member states plus Iceland, Norway, Northern Ireland and Liechtenstein.

PDF - https://mma.prnewswire.com/media/2009347/PR___Servier.pdf
Logo - https://mma.prnewswire.com/media/1914957/Servier_Logo.jpg

Contact: [email protected]


These press releases may also interest you

at 15:26
MEADOWS BEHAVIORAL HEALTHCARE SCREENS ACCIDENTALLY BRAVE FILM IN NEW YORK CITY
Meadows Behavioral Healthcare (MBH), the leader in trauma, addiction, eating disorders, and co-occurring disorder treatment for more than 45 years, recently partnered with actress Maddie Corman to showcase her new film, Accidentally Brave. The...

at 15:17
Space Needle Announces 8th Annual Base 2 Space Stair Climb to Benefit Fred Hutch Cancer Center and the Space Needle Foundation
The Space Needle is calling all climbers to Seattle on Sunday, September 29 for Base 2 Space, Seattle's Most Iconic Climb. Registration is now open for the annual charity stair climb, that challenges participants to scale the Space Needle's 832...

at 15:00
Cannara Biotech Reports Q2 2024 Financial Results
Cannara Biotech Inc. ("Cannara" or the "Company") (OTCQB:...

at 14:55
DWYER WORKFORCE DEVELOPMENT EXPANDS EFFORTS TO ALLEVIATE SENIOR HEALTHCARE STAFFING SHORTAGE AMID GROWING NATIONAL CRISIS
Jack and Nancy Dwyer Workforce Development Center, Inc. ("Dwyer Workforce Development" or "DWD") today announced its commitment to providing Certified Nursing Assistant (CNA) training and job placement support, case management, and wraparound...

at 14:40
New state data shows injured workers rate Pinnacol highest-performing workers' comp carrier in the state by a wide margin
Recent data from the Colorado Division of Workers' Compensation reveal that Pinnacol Assurance is again the top-performing workers' compensation carrier for injured workers, with a score far surpassing the scores of other carriers that operate in the...

at 14:37
New Perspective closes on more than $200 Million in capital and establishes a programmatic relationship for growth
New Perspective, a rapidly growing senior living company, has secured more than $200 million in bridge loan, preferred equity and common equity with its partners BMO, Fengate and Boldt to facilitate the acquisition and financing of six senior living...

More news about Health...


News published on and distributed by: